Fax: (613) 247-3511
Original Article
You have full text access to this OnlineOpen article
A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer
A Trial of the NCIC Clinical Trials Group
Article first published online: 18 NOV 2009
DOI: 10.1002/cncr.24745
Copyright © 2009 American Cancer Society
Additional Information
How to Cite
Laurie, S. A., Siu, L. L., Winquist, E., Maksymiuk, A., Harnett, E. L., Walsh, W., Tu, D. and Parulekar, W. R. (2010), A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer. Cancer, 116: 362–368. doi: 10.1002/cncr.24745
Publication History
- Issue published online: 20 JAN 2010
- Article first published online: 18 NOV 2009
- Manuscript Accepted: 14 MAY 2009
- Manuscript Received: 13 MAR 2009
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , Epithelial tumours of the lacrimal gland: a clinical, histopathological, surgical and oncological survey, Acta Ophthalmologica, 2012, 90, 4Direct Link:
- 2, , , Recurrent Salivary Gland Cancer, Current Treatment Options in Oncology, 2012, 13, 1, 58
- 3, , , , , Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review, The Lancet Oncology, 2011, 12, 8, 815
- 4, , What is new in the management of salivary gland cancers?, Current Opinion in Oncology, 2011, 23, 3, 249
- 5, , , , The status of platinum anticancer drugs in the clinic and in clinical trials, Dalton Transactions, 2010, 39, 35, 8113

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)